Allegations of DEA Bias Shake Up Rescheduling Talks
A filing submitted earlier this month accuses the U.S. Drug Enforcement Administration (DEA) of bias during the ongoing federal rescheduling hearings. The allegation stems from the DEA’s decision to exclude Colorado, a pioneering state in marijuana legalization, from the proceedings—despite allowing states without regulated markets, such as Nebraska and Tennessee, to participate. This exclusion has […]
Allegations of DEA Bias Shake Up Rescheduling Talks Read More »

